Cleviprex Approval History
FDA Approved: Yes (First approved August 1, 2008)
Brand name: Cleviprex
Generic name: clevidipine butyrate
Dosage form: Injectable Emulsion
Company: The Medicines Company
Treatment for: High Blood Pressure
Cleviprex (clevidipine) is an intravenous, ultrashort-acting calcium channel blocker under development for the treatment of severely elevated blood pressure in the hospital setting when oral therapy is not feasible or desirable.
Development History and FDA Approval Process for Cleviprex
|Aug 4, 2008||The Medicines Company’s Cleviprex Receives FDA Approval|
|Sep 14, 2007||FDA Accepts NDA Filing for Cleviprex (Clevidipine Butyrate Injectable Emulsion) for the Treatment of Acute Hypertension|
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.